FOLFIRI Plus Cetuximab Until Disease Progression vs FOLFIRI Plus Cetuximab With Cetuximab Maintenance for RAS/BRAF Wild-Type Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study
J. Clin. Oncol 2024 Jan 05;[EPub Ahead of Print], C Pinto, A Orlandi, N Normanno, E Maiello, MA Calegari, L Antonuzzo, R Bordonaro, MG Zampino, S Pini, F Bergamo, G Tonini, A Avallone, TP Latiano, G Rosati, AA Cogoni, A Ballestrero, A Zaniboni, M Roselli, S Tamberi, C BaroneFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.